Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: A case series and discussion of BRCA testing modalities

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 629-634

  Augustyn, Ann Marie ^a   Agostino, Nicole M ^a   Namey, Tara L ^a   Nair, Suresh ^a   Martino, Martin A ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

BRCA; Compound heterozygosity; Familial cancer

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; BLOATING; BREAST CANCER; CANCER RISK; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; ENDOMETRIUM CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; GERMLINE MUTATION; GYNECOLOGIC SURGERY; HETEROZYGOTE; HUMAN; OVARY CANCER; PATERNITY; PLEURA EFFUSION; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; WEIGHT REDUCTION;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HEREDITY; HUMANS; INCIDENTAL FINDINGS; JEWS; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 80052628603     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1597-9     Document Type: Article

References (34)

1. SJ Ramus LS Friedman SA Gayther, et al. 1997 A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2 Nat Genet 15 14 15 8988162 10.1038/ng0197-14 1:CAS:528:DyaK2sXjsVGqsQ%3D%3D
2. B Leegte AH van der Hout AM Deffenbaugh, et al. 2005 Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations J Med Genet 42 e20 15744030 10.1136/jmg.2004.027243 1:STN:280:DC%2BD2M7htlGisQ%3D%3D
3. Martin M, Ford C, Burbidge LA, Deffenbaugh A, et al. Myriad Genetic Laboratories, Inc Salt Lake City, UT. Poster Presentation at American Society of Human Genetics 56th Annual Meeting. October 9-13. New Orleans, LA
4. E Friedman R Bar-Sade Bruchim A Kruglikova, et al. 1998 Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes Am J Hum Genet 63 1224 1227 9758598 10.1086/302040 1:STN:280:DyaK1cvjtFyjug%3D%3D (Pubitemid 30418594)
5. TC Randall KA Bell BA Rebane, et al. 1998 Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient Gynecol Oncol 70 3 432 434 9790802 10.1006/gyno.1998.5081 1:STN:280:DyaK1M%2FgvFejtg%3D%3D (Pubitemid 28473649)
6. R Moslehi D Russo C Phelan, et al. 2000 An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2 Clin Genet 57 1 70 73 10733239 10.1034/j.1399-0004.2000.570111.x 1:STN:280:DC%2BD3c7psFektQ%3D%3D (Pubitemid 30105564)
7. DW Bell J Erban DC Sgroi, et al. 2002 Selective loss of heterozygosity in multiple breast cancer from a carrier of mutation in both BRCA1 and BRCA2 Cancer Res 62 2741 2743 12019146 1:CAS:528:DC%2BD38XjvFSmsbY%3D (Pubitemid 34525753)
8. G Tsongalis D Linfer R Johnson, et al. 1998 Double heterozygosity for mutations in BRCA1 and BRCA2 in a breast cancer patient Arch Pathol Lab Med 122 548 550 9625424 1:STN:280:DyaK1c3oslWjtA%3D%3D (Pubitemid 28262187)
9. TS Frank AM Deffenbaugh JE Reid, et al. 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals J Clin Oncol 20 1480 1490 11896095 10.1200/JCO.20.6.1480 1:CAS:528:DC%2BD38XivFeisbY%3D (Pubitemid 34260526)
10. J Prat A Ribe A Gallardo 2005 Hereditary ovarian cancer Hum Pathol 36 861 870 16112002 10.1016/j.humpath.2005.06.006 1:CAS:528:DC%2BD2MXos1Wqtrg%3D (Pubitemid 41187904)
11. O Lavie S Narod F Lejbkowica, et al. 2011 Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population Ann Oncol 22 964 966 10.1093/annonc/mdq460 20924075 10.1093/annonc/mdq460 1:STN:280: DC%2BC3MzkvVSquw%3D%3D
12. J Peto N Collins R Barfoot, et al. 1999 Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 943 949 10359546 10.1093/jnci/91.11.943 1:CAS:528:DyaK1MXjvFOmtb4%3D (Pubitemid 29272520)
13. S Loader PT Rowley 1998 Deleterious mutation of both BRCA1 and BRCA2 in three siblings Genet Test 2 75 77 10464601 10.1089/gte.1998.2.75 1:STN:280:DyaK1MzptlyltQ%3D%3D
14. A Tesoriero C Anderson M Southey, et al. 1999 De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation Am J Hum Genet 65 567 569 10417300 10.1086/302503 1:STN:280:DyaK1Mzksl2lsA%3D%3D (Pubitemid 30463015)
15. A Liede P Rehal D Vesprini, et al. 1998 A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2 Am J Hum Genet 62 1543 1544 9585617 10.1086/301889 1:CAS:528:DyaK1cXlslChsrk%3D (Pubitemid 28307127)
16. T Caldes M De la Hoya A Tosar S Sulleiro J Godino D Ibanez M Martin P Perez-Segura E Diaz-Rubio 2002 A breast cancer family from Spain with germline mutation in both BRCA1 and BRCA2 genes J Med Genet 39 8 e44 12161611 10.1136/jmg.39.8.e44 1:STN:280:DC%2BD38vgslSqtA%3D%3D
17. A Musolino N Naldi M Michiara, et al. 2005 A breast cancer family from Italy with germline mutations in both the BRCA1 and BRCA2 genes Breast Cancer Res Treat 91 203 205 15868448 10.1007/s10549-004-7704-4 (Pubitemid 40684932)
18. M Smith S Fawcett E Sigalas R Bell S Devery N Andrieska I Winship 2008 Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes Fam Cancer 7 119 124 17636421 10.1007/s10689-007-9154-8 1:CAS:528:DC%2BD1cXnt1Cisr4%3D (Pubitemid 351871903)
19. M Zuradelli B Peissel S Monoukian, et al. 2010 Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics Breast Cancer Res Treat 124 251 258 20373018 10.1007/s10549-010-0853-8 1:CAS:528:DC%2BC3cXht1elsLnL
20. C Cremin N Wong K Buzaglo A Paradis W Foulkes 2002 Nonovarian pelvic cancers in BRCA1/2 mutation carriers and the BRCAPRO statistical model J Clin Oncol 20 3936 3937 12228218 10.1200/JCO.2002.02.130
21. DH Choi MH Lee AE Ball D Carter B Haffty 2004 Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients J Clin Oncol 22 1638 1645 15117986 10.1200/JCO.2004.04.179 1:CAS:528:DC%2BD2cXpsVWmu7c%3D (Pubitemid 41079802)
22. DH Choi MH Lee B Haffty 2006 Double heterozygotes for Non-Caucasian families with mutations in BRCA-1 and BRCA-2 Genes Breast J 12 216 220 16684319 10.1111/j.1075-122X.2006.00245.x 1:CAS:528:DC%2BD28Xls1Squ70%3D (Pubitemid 43966634)
23. T Pal J Purmuth-Wey JA Betts, et al. 2005 BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases Cancer 104 2807 2816 16284991 10.1002/cncr.21536 1:CAS:528:DC%2BD28XptlSrsA%3D%3D (Pubitemid 41798292)
24. Myriad Genetic Laboratories, Inc. Services and Price List. April 2010
25. K Lu N Kauff CB Powell, et al. 2009 ACOG Practice Bulletin: hereditary breast and ovarian cancer syndrome Obstet Gynecol 113 957 966
26. American Society of Clinical Oncology, "Clinical Practice Guidelines," November 2010. http://www.asco.org. Accessed 12 Dec 2010
27. National Comprehensive Cancer Network, "Genetic/Familial High-Risk Assessment: Breast and Ovarian," November 2010. http://www.nccn.org. Accessed 12 Dec 2010
28. ClinicalTrial.gov. November 2010. www.clinicaltrials.gov/ct2/show/ NCT01102569. Accessed 12 Dec 2010
29. K Offit O Levran B Mullaney, et al. 2003 Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia J Natl Cancer Inst 95 1548 1551 14559878 1:CAS:528:DC%2BD3sXosVertbk%3D (Pubitemid 37322099)
30. D Thompson DF Easton 2002 Cancer incidence in BRCA1 Mutation Carriers J Natl Cancer Inst 94 1358 1365 12237281 1:CAS:528:DC%2BD38Xnt1Gnurs%3D (Pubitemid 35154140)
31. DA Levine PA Argenta CJ Yee, et al. 2003 Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 4222 4227 14615451 10.1200/JCO.2003.04.131 1:CAS:528:DC%2BD2cXpsVajtrc%3D (Pubitemid 46606192)
32. Abeloff MD, Armitage JO, Niederhuber JE et al (2008) Abeloff's clinical oncology, 4th edn. Churchill Livingstone Elsevier, PA
33. Devita VT Jr, Hellman S, Rosenberg SA et al (2008) Cancer principle and practice of oncology, 8th edn. Lippincott Williams and Wilkins, PA
34. The Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1310 1316 10.1093/jnci/91.15.1310